间质性肺疾病中身体衰弱的患病率及预后影响:一项前瞻性队列研究
该前瞻性队列研究纳入463例纤维性间质性肺疾病(ILD)患者,基于改良Fried身体衰弱标准分类:非衰弱18%、前衰弱56%、衰弱26%。中位随访1.71年期间发生56例死亡,前衰弱和衰弱患者死亡风险均显著高于非衰弱者,且独立于年龄、性别、肺功能及ILD-GAP评分。身体衰弱评估可为ILD提供额外预后价值,并可能作为可干预靶点。
要点
- 纤维性ILD患者中身体衰弱普遍存在,仅18%为非衰弱。
- 前衰弱和衰弱均独立增加死亡风险,aHR分别为4.14和4.41。
- 身体衰弱评估可补充ILD-GAP评分的预后信息,或为可干预靶点。
核心结论
- 身体衰弱在纤维性ILD患者中普遍存在,且独立与死亡风险增加相关。
- 身体衰弱评估为ILD-GAP评分等已知风险评分提供额外预后价值,并可能作为可干预靶点。
研究设计与样本
- 前瞻性队列研究,纳入McMaster大学ILD项目中2015年11月至2020年3月随访的纤维性ILD患者。
- 共纳入463例患者,55%为男性,平均(SD)年龄68(11)岁。
- 基于改良Fried身体衰弱标准将患者分为非衰弱(评分=0)、前衰弱(评分=1-2)和衰弱(评分=3-5)。
- 采用时间-事件模型评估身体衰弱与死亡的关联,并针对年龄、性别、肺功能及ILD-GAP评分诊断进行调整。
主要发现
- 463例患者中,82例(18%)为非衰弱,258例(56%)为前衰弱,123例(26%)为衰弱。
- 最常见ILD诊断为特发性肺纤维化(n=183,40%)和结缔组织病相关ILD(n=79,17%)。
- 自诊断以来平均时间为2.7±4.6年;中位随访1.71年(IQR 1.24,2.31)期间共发生56例死亡。
- 与基线非衰弱者相比,前衰弱者死亡风险调整后风险比(aHR)为4.14(95%CI 1.27-13.5),衰弱者为4.41(95%CI 1.29-15.1)。
关键数值与推荐
- 身体衰弱分类采用改良Fried身体衰弱标准:非衰弱评分=0,前衰弱评分=1-2,衰弱评分=3-5。
- 预后模型调整因素包括年龄、性别、肺功能及ILD-GAP评分诊断。
临床怎么用
- 在纤维性ILD患者中应评估身体衰弱状态,以识别死亡风险较高的前衰弱和衰弱患者。
- 身体衰弱评估可结合ILD-GAP评分等已知风险评分,提供额外预后信息。
- 身体衰弱可能作为可干预靶点,但需进一步研究验证干预效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Physical frailty is associated with increased mortality and hospitalizations in older adults. We describe the prevalence of physical frailty and its prognostic impact in patients with a spectrum of fibrotic interstitial lung disease (ILD). METHODS: Patients with fibrotic ILD at the McMaster University ILD programme were prospectively followed up from November 2015 to March 2020. Baseline data were used to classify patients as non-frail (score = 0), pre-frail (score = 1-2) or frail (score = 3-5) based on modified Fried physical frailty criteria. The association between physical frailty and mortality was assessed using time-to-event models, adjusted for age, sex, lung function and diagnosis using the ILD Gender-Age-Physiology (ILD-GAP) score. RESULTS: We included 463 patients (55% male, mean [SD] age 68 [11] years); 82 (18%) were non-frail, 258 (56%) pre-frail and 123 (26%) frail. The most common ILD diagnoses were idiopathic pulmonary fibrosis (n = 183, 40%) and connective tissue disease-associated-ILD (n = 79, 17%). Mean time since diagnosis was 2.7 ± 4.6 years. There were 56 deaths within the median follow-up of 1.71 (interquartile range [IQR] 1.24, 2.31) years. Both frail and pre-frail individuals had a higher risk of death compared to those categorized as non-frail at baseline (adjusted hazard ratio [aHR] 4.14, 95% CI 1.27-13.5 for pre-frail and aHR 4.41, 95% CI 1.29-15.1 for frail). CONCLUSION: Physical frailty is prevalent in patients with ILD and is independently associated with an increased risk of death. Assessment of physical frailty provides additional prognostic value to recognized risk scores such as the ILD-GAP score, and may present a modifiable target for intervention.
引用
- Farooqi MAM, O'Hoski S, Goodwin S, et al. Prevalence and prognostic impact of physical frailty in interstitial lung disease: A prospective cohort study. Respirology. 2021. PMID: 33876511. doi:10.1111/resp.14066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。